# Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in Real-World Practice

Study · id `cardio:ct-nct02017275` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02017275](<https://clinicaltrials.gov/study/NCT02017275>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02017275

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2348 participants.

## Technical summary

Registry record NCT02017275. Randomized; single masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2015-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2348 participants (enrolled count; ClinicalTrials.gov record NCT02017275, source copy `cardio:ctgov-nct02017275-2016-03-14`, retrieved 2026-11-18)
- Start date: 2013-11 (registry gives no type) (ClinicalTrials.gov record NCT02017275, source copy `cardio:ctgov-nct02017275-2016-03-14`, retrieved 2026-11-18)
- Primary completion: 2015-09 (actual) (ClinicalTrials.gov record NCT02017275, source copy `cardio:ctgov-nct02017275-2016-03-14`, retrieved 2026-11-18)
- Completion: Not reported
- Countries: China (ClinicalTrials.gov record NCT02017275, source copy `cardio:ctgov-nct02017275-2016-03-14`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02017275-2016-03-14`, retrieved 2026-11-18)

## The registry's words

- Brief title: Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in "Real-World" Practice
- Acronym: PANDA-III
- Condition: Coronary Artery Disease
- Intervention (Device): BuMA
- Intervention (Device): EXCEL
- Lead sponsor: Sino Medical Sciences Technology Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Sino Medical Sciences Technology Inc. (`cardio:org-sino-medical-sciences-technology-inc`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Biodegradable Polymer-Based Sirolimus-Eluting Stents With Differing Elution and Absorption Kinetics: The PANDA III Trial (`cardio:pubmed-27173037`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: \[Prognostic value of SYNTAX score on 1 year outcome in patients underwent percutaneous coronary intervention\] (`cardio:pubmed-29747321`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Outcomes of quantitative flow ratio-based percutaneous coronary intervention in an all-comers study (`cardio:pubmed-34219669`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 10e084f197715299621d820c9c836f110150774eaa2d28720a997b4e946f7406
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
